Measles-mumps-rubella vaccination and respiratory syncytial virus-associated hospital contact

Vaccine

Volumn 33, Issue 1, 2015, Pages 237-245

  Sørup, Signe ^a   Benn, Christine Stabell ^a,b   Stensballe, Lone Graff ^a,d   Aaby, Peter ^a,c   Ravn, Henrik ^a,b,c  

^a STATENS SERUM INSTITUT   (Denmark)

^b UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

^c BANDIM HEALTH PROJECT   (Guinea-Bissau)

^d Rigshospitalet   (Denmark)

Author keywords

Heterologous immunity; Immunization; Measles mumps rubella vaccination; Non specific effects; Non targeted effects; Respiratory syncytial virus

Indexed keywords

DIPHTHERIA VACCINE; HAEMOPHILUS INFLUENZAE TYPE B VACCINE; MEASLES MUMPS RUBELLA VACCINE; PERTUSSIS VACCINE; POLIOMYELITIS VACCINE; TETANUS TOXOID;

ARTICLE; CHILD; DENMARK; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; HOSPITAL INFECTION; HUMAN; MAJOR CLINICAL STUDY; MALE; MEASLES VACCINATION; RESPIRATORY SYNCYTIAL VIRUS INFECTION; SOCIAL STATUS; VACCINATION; ADOLESCENT; ADULT; COHORT ANALYSIS; HOSPITALIZATION; INCIDENCE; INFANT; MIDDLE AGED; RESPIRATORY SYNCYTIAL VIRUS INFECTIONS; YOUNG ADULT;

ADOLESCENT; ADULT; COHORT STUDIES; DENMARK; FEMALE; HOSPITALIZATION; HUMANS; INCIDENCE; INFANT; MALE; MEASLES-MUMPS-RUBELLA VACCINE; MIDDLE AGED; RESPIRATORY SYNCYTIAL VIRUS INFECTIONS; YOUNG ADULT;

EID: 84919346619     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2014.07.110     Document Type: Article

References (46)

1. Aaby P., Whittle H., Stabell Benn C. Vaccine programmes must consider their effect on general resistance. BMJ 2012, 344:e3769. [10.1136/bmj.e3769].
2. Flanagan K.L., van Crevel R., Curtis N., Shann F., Levy O., Optimmunize N. Heterologous ("nonspecific") and sex-differential effects of vaccines: epidemiology, clinical trials, and emerging immunologic mechanisms. Clin Infect Dis 2013, 57:283-289. [10.1093/cid/cit209].
3. Benn C.S., Netea M.G., Selin L.K., Aaby P. A small jab-a big effect: nonspecific immunomodulation by vaccines. Trends Immunol 2013, 34:431-439. [10.1016/j.it.2013.04.004].
4. Aaby P., Samb B., Simondon F., Seck A.M., Knudsen K., Whittle H. Non-specific beneficial effect of measles immunisation: analysis of mortality studies from developing countries. BMJ 1995, 311:481-485. [10.1136/bmj.311.7003.481].
5. Aaby P., Martins C.L., Garly M.L., Bale C., Andersen A., Rodrigues A., et al. Non-specific effects of standard measles vaccine at 4.5 and 9 months of age on childhood mortality: randomised controlled trial. BMJ 2010, 341:c6495. [10.1136/Bmj.C6495].
6. Aaby P., Roth A., Ravn H., Napirna B.M., Rodrigues A., Lisse I.M., et al. Randomized trial of BCG vaccination at birth to low-birth-weight children: beneficial nonspecific effects in the neonatal period?. J Infect Dis 2011, 204:245-252. [10.1093/infdis/jir240].
7. Biering-Sorensen S., Aaby P., Napirna B.M., Roth A., Ravn H., Rodrigues A., et al. Small randomized trial among low-birth-weight children receiving bacillus Calmette-Guerin vaccination at first health center contact. Pediatr Infect Dis J 2012, 31:306-308. [10.1097/INF.0b013e3182458289].
8. Shann F. The non-specific effects of vaccines. Arch Dis Child 2010, 95:662-667. [10.1136/adc.2009.157537].
9. Aaby P., Jensen H., Gomes J., Fernandes M., Lisse I.M. The introduction of diphtheria-tetanus-pertussis vaccine and child mortality in rural Guinea-Bissau: an observational study. Int J Epidemiol 2004, 33:374-380. [10.1093/ije/dyh005].
10. Aaby P., Benn C.S., Nielsen J., Lisse I.M., Rodrigues A., Ravn H. Testing the hypothesis that diphtheria-tetanus-pertussis vaccine has negative non-specific and sex-differential effects on child survival in high-mortality countries. BMJ Open 2012, 2:e000707. [10.1136/bmjopen-2011-000707].
11. Aaby P., Ravn H., Roth A., Rodrigues A., Lisse I.M., Diness B.R., et al. Early diphtheria-tetanus-pertussis vaccination associated with higher female mortality and no difference in male mortality in a cohort of low birthweight children: an observational study within a randomised trial. Arch Dis Child 2012, 97:685-691. [10.1136/archdischild-2011-300646].
12. Aaby P., Benn C.S. Non-specific and sex-differential effects of routine vaccines: what evidence is needed to take these effects into consideration in low-income countries?. Hum Vaccin 2011, 7:120-124. [10.4161/hv.7.1.13848].
13. Veirum J.E., Sodemann M., Biai S., Jakobsen M., Garly M.L., Hedegaard K., et al. Routine vaccinations associated with divergent effects on female and male mortality at the paediatric ward in Bissau, Guinea-Bissau. Vaccine 2005, 23:1197-1204. [10.1016/j.vaccine.2004.02.053].
14. Valentiner-Branth P., Perch M., Nielsen J., Steinsland H., Garly M.L., Fischer T.K., et al. Community cohort study of Cryptosporidium parvum infections: sex-differential incidences associated with BCG and diphtheria-tetanus-pertussis vaccinations. Vaccine 2007, 25:2733-2741. [10.1016/j.vaccine.2006.01.035].
15. Rodrigues A., Fischer T.K., Valentiner-Branth P., Nielsen J., Steinsland H., Perch M., et al. Community cohort study of rotavirus and other enteropathogens: are routine vaccinations associated with sex-differential incidence rates?. Vaccine 2006, 24:4737-4746. [10.1016/j.vaccine.2006.03.033].
16. Stensballe L.G., Nante E., Jensen I.P., Kofoed P.E., Poulsen A., Jensen H., et al. Acute lower respiratory tract infections and respiratory syncytial virus in infants in Guinea-Bissau: a beneficial effect of BCG vaccination for girls community based case-control study. Vaccine 2005, 23:1251-1257. [10.1016/j.vaccine.2004.09.006].
17. Martins C.L., Benn C.S., Andersen A., Bale C., Schaltz-Buchholzer F., Do V.A., et al. A randomized trial of a standard dose of Edmonston-Zagreb measles vaccine given at 4.5 months of age: effect on total hospital admissions. J Infect Dis 2014, 209:1731-1738. [10.1093/infdis/jit804].
18. Sorup S., Villumsen M., Ravn H., Benn C.S., Sorensen T.I., Aaby P., et al. Smallpox vaccination and all-cause infectious disease hospitalization: a Danish register-based cohort study. Int J Epidemiol 2011, 40:955-963. [10.1093/ije/dyr063].
19. Sorup S., Benn C.S., Poulsen A., Krause T.G., Aaby P., Ravn H. Live vaccine against measles, mumps, and rubella and the risk of hospital admissions for nontargeted infections. JAMA 2014, 311:826-835. [10.1001/jama.2014.470].
20. Garcia-Garcia M.L., Calvo C., Pozo F., Villadangos P.A., Perez-Brena P., Casas I. Spectrum of respiratory viruses in children with community-acquired pneumonia. Pediatr Infect Dis J 2012, 31:808-813. [10.1097/INF.0b013e3182568c67].
21. Nair H., Nokes D.J., Gessner B.D., Dherani M., Madhi S.A., Singleton R.J., et al. Global burden of acute lower respiratory infections due to respiratory syncytial virus in young children: a systematic review and meta-analysis. Lancet 2010, 375:1545-1555. [10.1016/S0140-6736(10)60206-1].
22. Law B.J., Carbonell-Estrany X., Simoes E.A. An update on respiratory syncytial virus epidemiology: a developed country perspective. Respir Med 2002, 96(Suppl B):S1-S7. [10.1053/rmed.2002.1294].
23. Pedersen C.B. The Danish Civil Registration System. Scand J Public Health 2011, 39:22-25. [10.1177/1403494810387965].
24. Andersen J.S., Olivarius N.D.F., Krasnik A. The Danish National Health Service Register. Scand J Public Health 2011, 39:34-37. [10.1177/1403494810394718].
25. Pedersen P.A., Hollnagel H., Olivarius N.F., Reusch S., Sorensen M., Thorsen H. Individual registration of children in the national health service. New possibilities for epidemiological research in primary health care. Ugeskr Laeger 1999, 161:6351-6354.
26. Stensballe L.G., Kristensen K., Nielsen J., Aaby P. Diagnosis coding in The Danish National Patient Registry for respiratory syncytial virus infections. Scand J Infect Dis 2005, 37:747-752. [10.1080/00365540510012107].
27. Knudsen L.B., Olsen J. The Danish Medical Birth Registry. Dan Med Bull 1998, 45:320-323.
28. Lynge E., Sandegaard J.L., Rebolj M. The Danish National Patient Register. Scand J Public Health 2011, 39:30-33. [10.1177/1403494811401482].
29. Baadsgaard M., Quitzau J. Danish registers on personal income and transfer payments. Scand J Public Health 2011, 39:103-105. [10.1177/1403494811405098].
30. Jensen V.M., Rasmussen A.W. Danish Education Registers. Scand J Public Health 2011, 39:91-94. [10.1177/1403494810394715].
31. Barros A.J., Hirakata V.N. Alternatives for logistic regression in cross-sectional studies: an empirical comparison of models that directly estimate the prevalence ratio. BMC Med Res Methodol 2003, 3:21. [10.1186/1471-2288-3-21].
32. Okiro E.A., White L.J., Ngama M., Cane P.A., Medley G.F., Nokes D.J. Duration of shedding of respiratory syncytial virus in a community study of Kenyan children. BMC Infect Dis 2010, 10:15. [10.1186/1471-2334-10-15].
33. Kristensen K., Hjuler T., Ravn H., Simoes E.A., Stensballe L.G. Chronic diseases, chromosomal abnormalities, and congenital malformations as risk factors for respiratory syncytial virus hospitalization: a population-based cohort study. Clin Infect Dis 2012, 54:810-817. [10.1093/cid/cir928].
34. Wojcik O.P., Simonsen J., Molbak K., Valentiner-Branth P. Validation of the 5-year tetanus, diphtheria, pertussis and polio booster vaccination in the Danish childhood vaccination database. Vaccine 2013, 31:955-959. [10.1016/j.vaccine.2012.11.100].
35. Henrickson K.J., Hall C.B. Diagnostic assays for respiratory syncytial virus disease. Pediatr Infect Dis J 2007, 26:S36-S40. [10.1097/INF.0b013e318157da6f].
36. Stowe J., Andrews N., Taylor B., Miller E. No evidence of an increase of bacterial and viral infections following measles, mumps and rubella vaccine. Vaccine 2009, 27:1422-1425. [10.1016/j.vaccine.2008.12.038].
37. Mullooly J.P., Schuler R., Mesa J., Drew L., DeStefano F. Wheezing lower respiratory disease and vaccination of premature infants. Vaccine 2011, 29:7611-7617. team V.S.D., [10.1016/j.vaccine.2011.08.022].
38. Aaby P., Garly M.L., Bale C., Martins C., Jensen H., Lisse I., et al. Survival of previously measles-vaccinated and measles-unvaccinated children in an emergency situation: an unplanned study. Pediatr Infect Dis J 2003, 22:798-805. [10.1097/01.inf.0000083821.33187.b5].
39. Desgrees du L.A., Pison G., Aaby P. Role of immunizations in the recent decline in childhood mortality and the changes in the female/male mortality ratio in rural Senegal. Am J Epidemiol 1995, 142:643-652.
40. Sommer C., Resch B., Simoes E.A. Risk factors for severe respiratory syncytial virus lower respiratory tract infection. Open Microbiol J 2011, 5:144-154. [10.2174/1874285801105010144].
41. Stensballe L.G., Kristensen K., Simoes E.A., Jensen H., Nielsen J., Benn C.S., et al. Atopic disposition, wheezing, and subsequent respiratory syncytial virus hospitalization in Danish children younger than 18 months: a nested case-control study. Pediatrics 2006, 118:e1360-e1368. [10.1542/peds.2006-0907].
42. Kleinnijenhuis J., Quintin J., Preijers F., Joosten L.A., Ifrim D.C., Saeed S., et al. Bacille Calmette-Guerin induces NOD2-dependent nonspecific protection from reinfection via epigenetic reprogramming of monocytes. Proc Natl Acad Sci USA 2012, 109:17537-17542. [10.1073/pnas.1202870109].
43. Welsh R.M., Che J.W., Brehm M.A., Selin L.K. Heterologous immunity between viruses. Immunol Rev 2010, 235:244-266. [10.1111/j.0105-2896.2010.00897.x].
44. Ziola B., Smith R.H. T cell cross-reactivity among viruses of the paramyxoviridae. Viral Immunol 1987, 1:111-119.
45. Ziola B., Karvonen B., Stewart J. Prior infection by respiratory syncytial virus or parainfluenza viruses augments virus-specific IgG responses induced by the measles/mumps/rubella vaccine. Viral Immunol 1994, 7:205-214.
46. Meeting of the Strategic Advisory Group of Experts on immunization, April 2014-conclusions and recommendations. Wkly Epidemiol Rec 2014;89:221-36.